UFC flyweight pops for banned substance
Flyweight Ramazan Temirov won’t fight again until at least 2026 after he received a one-year suspension for a positive drug test under the UFC’s anti-doping policy.
Combat Sports Anti-Doping (CSAD) announced the suspension Wednesday.
“Temirov tested positive for the presence of Trimetazidine (TMZ), a drug used to treat heart failure and other cardiac conditions, in the class of hormone and metabolic modulators under the UFC [anti-doping policy] prohibited list,” CSAD officials said in a statement. “TMZ is prohibited at all times under the UFC ADP and was present in samples collected out-of-competition from Temirov on June 12, 2025, in Phuket, Thailand, and out-of-competition on July 4, 2025, also in Phuket, Thailand.
“Because Temirov was not notified of the June 12, 2025, adverse finding for TMZ until after the collection on July 4, 2025, both adverse findings are combined into one violation under the UFC ADP rules.”
CSAD officials said Temirov admitted to his TMZ use and explained it was a prescribed medicine, but he “failed to check on the status of this medication before he used it and failed to notify his prescribing doctor that he was a tested athlete.”
Temirov has been hit with a one-year suspension that officially started on July 5, which means he is eligible to compete again on or after July 5, 2026.
Temirov is currently 2-0 in the UFC with his biggest win coming back in March when he defeated flyweight veteran Charles Johnson via unanimous decision. Overall, Temirov holds a 19-2 record in his career.
Category: General Sports
